Key facts
- Verse Medical’s last known valuation is $772.0M (Jun 2025).
- It has raised $108.1M; the latest was Later Stage VC ($53.0M) in Jun 2025.
- Notable investors include Y Combinator, Soma Capital, Pareto Holdings, Abstract Ventures, FundersClub — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Verse Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Verse Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Verse Medical
Developer of healthcare software intended to provide reliable, timely, and affordable care for patients in their homes. The company's software provides a robust infrastructure to offer the transition from the hospital to the home or the outpatient center to their homes, enabling patients to receive an in-home care experience seamlessly and healthcare administration and clinicians to save time.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 136
- Website
- versemedical.com/
- Ownership
- Privately Held (backing)
Verse Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Verse Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Verse Medical in its N-PORT filings yet. We sweep new filings monthly.